REDWOOD CITY, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, ...
Following completion of the ongoing Phase 2a proof-of-pharmacology study with BMB-101, Bright Minds plans to select and ...
A gene on the X chromosome revs up inflammation in the female brain, which may explain why rates of multiple sclerosis are ...
This insightful review explores key areas of cancer genetic research, focusing on genes that may benefit from ...
1don MSN
‘Welcome Home Angel’: Family gets life-changing home renovation for daughter with rare disorder
A 15-year-old girl with a rare chromosome disorder received a complete room renovation Friday that her family says will ...
When Skye Scott took her son to a paediatrician, she never imagined he would be diagnosed with the life-changing Duchenne ...
The international research team, which included CSIR-Centre for Cellular and Molecular Biology (CCMB), discovered that ...
Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Dasatinib Tablets in strengths ...
1don MSNOpinion
The electoral republic of vote benefit transfers
India’s political landscape is witness to an innovative private-public partnership model. The upgrades are rapid and arrive ...
The NEET Registry is the most comprehensive research project of its kind to look beyond pregnancy success to observe a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback